BMJ Best Practice

参考文献

关键文献

Harris AM, Hicks LA, Qaseem A, et al. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med. 2016;164:425-434.

Smith SM, Fahey T, Smucny J, et al. Antibiotics for acute bronchitis. Cochrane Database Syst Rev. 2017;(6):CD000245.

参考文章

1.  MacFarlane J, Holmes W, Gard P, et al. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax. 2001;56:109-114.

2.  Williamson HA Jr. Pulmonary function tests in acute bronchitis: evidence for reversible airway obstruction. J Fam Pract. 1987;25:251-256.

3.  Harris AM, Hicks LA, Qaseem A, et al. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med. 2016;164:425-434.

4.  Gulliford MC, van Staa T, McDermott L, et al. Cluster randomised trial in the general practice research database: 1. electronic decision support to reduce antibiotic prescribing in primary care (eCRT study). Trials. 2011;12:115.

5.  Adams P, Hendershot G, Marano M, eds. Current Estimates From the National Health Interview Survey, 1996. Hyattsville, MD: US Department of Health and Human Services, Public Health Service, Office of Health Research, Statistics and Technology. National Center for Health Statistics; 1999.

6.  King DE, Williams WC, Bishop L, et al. Effectiveness of erythromycin in the treatment of acute bronchitis. J Fam Pract. 1996;42:601-605.

7.  Chen H, Zhuo Q, Yuan W, et al. Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age. Cochrane Database Syst Rev. 2008;(1):CD006090.

8.  Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356::i6583.

9.  Ginde AA, Blatchford P, Breese K, et al. High-dose monthly vitamin D for prevention of acute respiratory infection in older long-term care residents: a randomized clinical trial. J Am Geriatr Soc. 2017;65:496-503.

10.  American College of Radiology. ACR appropriateness criteria: hemoptysis. 2014. http://www.acr.org (last accessed 18 August 2017).

11.  Gonzales R, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med. 2001;134:521-529.

12.  Melbye H, Kongerud J, Vorland L. Reversible airflow limitation in adults with respiratory infection. Eur Resp J. 1994; 7: 1239-1245.

13.  Becker LA, Hom J, Villasis-Keever M, et al. Beta2-agonists for acute cough or a clinical diagnosis of acute bronchitis. Cochrane Database Syst Rev. 2015;(9):CD001726.

14.  Prabhu Shankar S, Chandrashekharan S, Bolmall CS, et al. Efficacy, safety and tolerability of salbutamol + guaiphenesin + bromhexine (Ascoril) expectorant versus expectorants containing salbutamol and either guaiphenesin or bromhexine in productive cough: a randomised controlled comparative study. J Indian Med Assoc. 2010;108:313-314;316-318;320.

15.  Public Health England. Management of infection guidance for primary care for consultation and local adaptation. August 2017. https://www.gov.uk/ (last accessed 18 August 2017).

16.  National Institute for Health and Care Excellence. Respiratory tract infections (self-limiting): prescribing antibiotics. July 2008. https://www.nice.org.uk/ (last accessed 18 August 2017).

17.  Little P, Stuart B, Smith S, et al. Antibiotic prescription strategies and adverse outcome for uncomplicated lower respiratory tract infections: prospective cough complication cohort (3C) study. BMJ. 2017;357:j2148.

18.  de la Poza Abad M, Mas Dalmau G, Moreno Bakedano M, et al; Delayed Antibiotic Prescription Group. Prescription strategies in acute uncomplicated respiratory infections: a randomized clinical trial. JAMA Intern Med. 2016;176:21-29.

19.  Llor C, Bjerrum L. Antibiotic prescribing for acute bronchitis. Expert Rev Anti Infect Ther. 2016;14:633-642.

20.  Smith SM, Fahey T, Smucny J, et al. Antibiotics for acute bronchitis. Cochrane Database Syst Rev. 2017;(6):CD000245.

21.  Kraus EM, Pelzl S, Szecsenyi J, et al. Antibiotic prescribing for acute lower respiratory tract infections (LRTI) - guideline adherence in the German primary care setting: an analysis of routine data. PLoS One. 2017;12:e0174584.

22.  Marchant JM, Morris P, Gaffney JT, et al. Antibiotics for prolonged moist cough in children. Cochrane Database Syst Rev. 2005;(4):CD004822

23.  Shields MD, Bush A, Everard ML, et al; British Thoracic Society Cough Guideline Group. BTS guidelines: recommendations for the assessment and management of cough in children. Thorax. 2008;63(suppl 3):iii1-iii15.

24.  Hueston WJ. Albuterol delivered by metered-dose inhaler to treat acute bronchitis. J Fam Pract. 1994;39;437-440.

25.  Hueston WJ. A comparison of albuterol and erythromycin for the treatment of acute bronchitis. J Fam Pract. 1991;33:476-480.

26.  Timmer A, Günther J, Motschall E, et al. Pelargonium sidoides extract for acute respiratory tract infections. Cochrane Database Syst Rev. 2013;(10):CD006323.

27.  Agbabiaka T, Guo R, Ernst E. Pelargonium sidoides for acute bronchitis: A systematic review and meta-analysis. Phytomedicine. 2008;15:378-385.

28.  Kamin W, Maydannik V, Malek FA, et al. Efficacy and tolerability of EPs 7630 in children and adolescents with acute bronchitis: a randomized, double-blind, placebo-controlled multicenter trial with a herbal drug preparation from Pelargonium sidoides roots. Int J Clin Pharmacol Ther. 2010;48:184-191.

29.  Kamin W, Maydannik VG, Malek FA, et al. Efficacy and tolerability of EPs 7630 in patients (aged 6-18 years old) with acute bronchitis. Acta Paediatr. 2010;99:537-543.

30.  Matthys H, Lizogub VG, Malek FA, et al. Efficacy and tolerability of EPs 7630 tablets in patients with acute bronchitis: a randomised, double-blind, placebo-controlled dose-finding study with a herbal drug preparation from Pelargonium sidoides. Curr Med Res Opin. 2010;26:1413-1422.

31.  Ding HY, Zhang N-ZW, Chen B, et al. A multicentered, double-blind, randomized controlled trials of Gankeshuangqing Capsule in the treatment of wind-heat syndrome (acute upper respiratory infection or acute bronchitis). Chin J Evid Based Med. 2010;1:14-22.

32.  Kemmerich B, Eberhardt R, Stammer H. Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough: a prospective, double-blind, placebo-controlled clinical trial. Arzneimittelforschung. 2006;56:652-660.

33.  Cwientzek U, Ottillinger B, Arenberger P. Acute bronchitis therapy with ivy leaves extracts in a two-arm study. A double-blind, randomised study vs. an other ivy leaves extract. Phytomedicine. 2011;18:1105-1109.

34.  Fischer J, Dethlefsen U. Efficacy of cineole in patients suffering from acute bronchitis: a placebo-controlled double-blind trial. Cough. 2013;9:25.

35.  Gillissen A, Wittig T, Ehmen M, et al. A multi-centre, randomised, double-blind, placebo-controlled clinical trial on the efficacy and tolerability of GeloMyrtol® forte in acute bronchitis. Drug Res (Stuttg). 2013;63:19-27.

使用此内容应接受我们的免责声明